BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

77 Articles

Jon C. Ogg | Jan 25, 2020 at 2:35 PM EST

Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies

The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As…

Chris Lange | May 21, 2019 at 10:10 AM EDT

Why BioCryst’s HAE Treatment Failed to Impress

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary…

Lee Jackson | May 11, 2019 at 8:55 AM EDT

Jefferies Says Buy These 5 Sizzling Stocks Under $10

Every week we search for stocks covered by top Wall Street analysts that are trading under the $10 level and…

Lee Jackson | Oct 20, 2018 at 9:20 AM EDT

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and…

Chris Lange | Sep 4, 2018 at 9:50 AM EDT

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.

Jon C. Ogg | Jul 17, 2018 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft, Netflix and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft…

Chris Lange | Jul 11, 2018 at 11:05 AM EDT

BioCryst Shareholders Back Out of Idera Merger

Idera Pharmaceuticals shares crumbled on Wednesday after BioCryst Pharmaceuticals announced that it terminated the merger agreement.

Lee Jackson | Jun 22, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More

The top analyst upgrades, downgrades and other research calls from Friday include Bookings Holdings, Dollar General, KLA-Tencor, Micron Technology, Nike…

Jon C. Ogg | Jan 2, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM,…

Chris Lange | Sep 21, 2017 at 9:55 AM EDT

Can BioCryst Turn Itself Around With This FDA Approval?

BioCryst Pharmaceuticals has received an update from the FDA. This approval is very welcome as BioCryst has been underperforming the…

Chris Lange | Sep 12, 2017 at 10:50 AM EDT

BioCryst Pharmaceuticals Announces Secondary Offering

BioCryst Pharmaceuticals watched its shares fall handily on Tuesday after the firm announced a secondary offering.

Jon C. Ogg | Sep 6, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: BioCryst, Exxon, FCA, HPE, IAMGOLD, Mallinckrodt, Rockwell Collins and More

The include BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt and Rockwell Collins.

Chris Lange | Sep 5, 2017 at 10:35 AM EDT

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its…

Jon C. Ogg | Feb 16, 2017 at 10:20 AM EST

Top Analyst Upgrades and Downgrades: BioCryst, Cisco, Groupon, SunPower, Tesla, Wells Fargo and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday include BioCryst Pharmaceuticals, Cisco Systems, Groupon, SunPower, Tesla and Wells…

Chris Lange | Mar 29, 2016 at 9:35 AM EDT

8 Major Biopharma Events Coming Later in 2016 and in 2017

FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in…

1 2 3 4 … 6

BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies

Why BioCryst’s HAE Treatment Failed to Impress

Jefferies Says Buy These 5 Sizzling Stocks Under $10

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

Top Analyst Upgrades and Downgrades: Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft, Netflix and More

BioCryst Shareholders Back Out of Idera Merger

Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

Can BioCryst Turn Itself Around With This FDA Approval?

BioCryst Pharmaceuticals Announces Secondary Offering

Top Analyst Upgrades and Downgrades: BioCryst, Exxon, FCA, HPE, IAMGOLD, Mallinckrodt, Rockwell Collins and More

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

Top Analyst Upgrades and Downgrades: BioCryst, Cisco, Groupon, SunPower, Tesla, Wells Fargo and Many More

8 Major Biopharma Events Coming Later in 2016 and in 2017

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies

Why BioCryst’s HAE Treatment Failed to Impress

Jefferies Says Buy These 5 Sizzling Stocks Under $10

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

BioCryst Pharmaceuticals Stock Retreats After HAE Study Results

Top Analyst Upgrades and Downgrades: Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft, Netflix and More

BioCryst Shareholders Back Out of Idera Merger

Top Analyst Upgrades and Downgrades: Dollar General, KLA-Tencor, Micron Technology, Nike, Red Hat and More

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

Can BioCryst Turn Itself Around With This FDA Approval?

BioCryst Pharmaceuticals Announces Secondary Offering

Top Analyst Upgrades and Downgrades: BioCryst, Exxon, FCA, HPE, IAMGOLD, Mallinckrodt, Rockwell Collins and More

BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win

Top Analyst Upgrades and Downgrades: BioCryst, Cisco, Groupon, SunPower, Tesla, Wells Fargo and Many More

8 Major Biopharma Events Coming Later in 2016 and in 2017

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026